Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404661 · ClinicalTrials.gov registry record
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 346
- Enrollment target
NCT03404661: Completed study, sponsored by Mayo Clinic.
NCT03404661 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 346 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03404661 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 346 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a test for detection of pancreatic cancer by looking at the subject's DNA.
Interventions
- DRUG Synthetic Human Secretin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2018-01-11 |
| Est. Completion | 2022-03-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03404661
The ClinicalTrials.gov registry entry for NCT03404661 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 346 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Synthetic Human Secretin is the first listed.
NCT03404661 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03404661 about?
NCT03404661 is a clinical study titled "Optical and Biochemical Biomarkers in Early Pancreatic Cancer". The purpose of this study is to develop a test for detection of pancreatic cancer by looking at the subject's DNA.
What is the current status of trial NCT03404661?
This trial is currently completed. The enrollment target is 346 participants. The study started on 2018-01-11. Estimated completion is 2022-03-10.
What interventions are being tested in trial NCT03404661?
The interventions under investigation include: Synthetic Human Secretin (DRUG).
Who is sponsoring clinical trial NCT03404661?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.